Postoperative Outcomes of the Largest HeartMate-II Experience in Turkey

ERTUGAY S. , ENGİN Ç. , NALBANTGİL S. , Kocabas S. , BALCIOGLU O., ENGIN Y., ...More

TRANSPLANTATION PROCEEDINGS, vol.47, no.5, pp.1499-1502, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.1016/j.transproceed.2015.04.046
  • Title of Journal : TRANSPLANTATION PROCEEDINGS
  • Page Numbers: pp.1499-1502

Abstract

Introduction. HeartMate II (HMII; Thoratec Corporation, Pleasanton, Calif, United States) is a continuous-flow pump approved by the Food and Drug Administration (FDA) for bridge-to-transplantation (BIT) since 2008 and for destination therapy (DT) since 2010. Herein, we present the postoperative outcomes of HMII implantation due to end-stage heart failure in our center.